Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4374-4381

  McMichael, John C ^a,b   Fiske, Michael J ^a   Fredenburg, Ross A ^a   Chakravarti, Deb N ^a   VanDerMeid, Karl R ^a   Barniak, Vicki ^a   Caplan, Jeffrey ^a   Bortell, Eric ^a   Baker, Steven ^a   Arumugham, Rasappa ^a   Chen, Dexiang ^a  

^a PFIZER INC   (United States)

^b Wyeth Lederle Vaccines   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; CELL PROTEIN; PROTEIN USPA1; PROTEIN USPA2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BINDING AFFINITY; CROSS REACTION; FEMALE; IMMUNIZATION; IMMUNOGENICITY; LUNG CLEARANCE; MOLECULAR WEIGHT; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN PURIFICATION; RESPIRATORY TRACT INFECTION; SEQUENCE ANALYSIS;

EID: 17344379355     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.9.4374-4381.1998     Document Type: Article

References (28)

1. Aebi, C., E. R. Lafontaine, L. D. Cope, J. L. Latimer, S. L. Lumbiey, G. H. McCracken, and E. J. Hansen. 1998. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis O35E. Infect. Immun. 66:3113-3119.
2. Aebi, C., I. Maciver, J. L. Latimer, L. D. Cope, M. K. Stevens, S. E. Thomas, G. H. McCracken, and E. J. Hansen. 1997. A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect. Immun. 65:4367-4377.
3. Boyle, F. M., P. R. Georghiou, M. H. Tilse, and J. G. McCormack. 1991. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med. J. Aust. 154:592-596.
4. Chen, D., J. C. McMichael, K. R. VanDerMeid, D. Hahn, T. Mininni, J. Cowell, and J. Eldridge. 1996. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect. Immun. 64:1900-1905.
5. Davies, B. I., and F. P. V. Maesen. 1988. The epidemiology of respiratory tract pathogens in Southern Netherlands. Eur. Respir. J. 1:415-420.
6. Dehio, M., O. G. Gómez-Duarte, C. Dehio, and T. F. Meyer. 1998. Vitronectin-dependent invation of epithelial cells by Neisseria gonorrhoeae involves αv intrgrin receptors. FEBS Lett. 424:84-88.
7. Gómez-Duarte, O. G., M. Dehio, C. A. Guzman, G. S. Chhatwal, C. Dehio, and T. F. Meyer. 1997. Binding of vitronectin to Opa-expressing Neisseria gonorrhoeae mediates invasion of HeLa cells. Infect. Immun. 65:3857-3866.
8. Gottfarb, P., and A. Brauner. 1994. Children with persistent cough-outcome with treatment and role of Moraxella catarrhalis. Scand. J. Infect. Dis. 26:545-551.
9. Gu, X.-X., J. Chen, S. J. Barenkamp, J. B. Robbins, C.-M. Tsai, D. J. Lim, and J. Battey. 1998. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarralis. Infect. Immun. 66:1891-1897.
10. Hager, H., A. Verghese, S. Alverez, and S. L. Berk. 1987. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1140-1149.
11. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. Paris, G. H. McCracken, and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872.
12. Hillenkamp, F., and M. Karas. 1990. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol. 193:280-295.
13. Hol, C., C. M. Verduin, E. van Dijke, J. Verhoef, and H. van Dijk. 1993. Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet 341:1281.
14. Klingman, K. L., and T. F. Murphy. 1994. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1150-1155.
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Limper, A. H., J. E. Standing, O. A. Huffman, M. Castro, and L. W. Neese. 1993. Vitronectin binds to Pneumocystis carnii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61:4302-4309.
17. Ljungh, Ä., and T. Wadström. 1995. Binding of extracellular matrix proteins by microbes. Methods Enzymol. 253:501-514.
18. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262:10035-10038.
19. Murphy, T. F. 1996. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:267-279.
20. O'Shea, E. K., J. D. Klemm, P. S. Kim, and T. Alber. 1991. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254:539-544.
21. Preissner, K. T. 1991. Structure and biological role of vitronectin. Annu. Rev. Cell Biol. 7:275-310.
22. Schägger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
23. Schalen, L., I. Eliasson, S. Fex, C. Kamme, and C. Schalen. 1992. Acute laryngitis in adults: results of erythromycin treatment. Acta Otolaryngol. Suppl. (Stockholm) 492:55-57.
24. Seiffert, D. 1997. Constitutive and regulated expression of vitronectin. Histol. Histopathol. 12:787-797.
25. Su, H. R. 1996. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex. Int. Arch. Allergy Immunol. 110:314-317.
26. van Cauwenberge, P. B., M. A. M. Vander, and K. J. Ingels. 1993. The microbiology of acute and chronic sinusitis and otitis media: a review. Eur Arch Otorhinolaryngol 250(Suppl. 1):S3-S6.
27. Verduin, C. M., M. Jansze, C. Hol, T. E. Mollines, J. Verhoef, and H. van Dijk. 1994. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect. Immun. 62:589-595.
28. Westerlund, B., and I. K. Korhonen. 1993. Bacterial protein binding to mammalian extracellular matrix. Mol. Microbiol. 9:687-694.